Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
2024年3月12日 - 2:48AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
(Amendment No. 1)
Tender Offer Statement Pursuant to Section 14(d)(1) or
13(e)(1)
of the Securities Exchange Act of 1934
CNL
HEALTHCARE PROPERTIES, INC.
(Name of Subject Company (Issuer))
COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP
COMRIT INVESTMENTS LTD.
(Bidders)
COMMON STOCK, $0.01 PAR VALUE PER SHARE
(Title of Class of Securities)
None or unknown
(CUSIP Number of Class of Securities)
Ziv Sapir
Comrit Investments 1, Limited Partnership
9 Ahad Ha’am Street
Tel Aviv, Israel 6129101
+ 972-3-519-9936
(Name, Address, and Telephone Number of
Person Authorized to Receive Notices and
Communications on Behalf of Filing Persons)
Copy
to:
Amos W. Barclay
Holland & Hart LLP
1800 Broadway, Suite 300
Boulder, Colorado 80302
Phone: (303) 473-2700
¨ |
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
|
|
|
Check the appropriate boxes below to designate any transactions to which the statement relates: |
|
|
x |
third party tender offer subject to Rule 14d-1. |
¨ |
issuer tender offer subject to Rule 13e-4. |
¨ |
going private transaction subject to Rule 13e-3 |
¨ |
amendment to Schedule 13D under Rule 13d-2 |
|
|
|
Check the following box if the filing is a final amendment reporting the results of the tender offer: x |
|
|
|
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon: |
|
|
¨ |
Rule 13e-4(i) (Cross-Border Issuer Tender
Offer)
|
¨ |
Rule 14d-1(d) (Cross-Border Third-Party
Tender Offer)
|
FINAL AMENDMENT TO TENDER OFFER
This Final Amendment to the Tender Offer Statement
on Schedule TO relates to the offer (the “Offer”) by Comrit Investments 1, Limited Partnership (the “Purchaser”)
to purchase up to up to 8,800,000 shares of common stock, par value $0.01 per share (the “Shares”), in CNL Healthcare Properties, Inc.,
the subject company, at a purchase price of $3.94 per Share, upon the terms and subject to the conditions set forth in the Offer to Purchase,
dated January 8, 2024, and the related Assignment Form.
The Offer resulted in the tender by shareholders,
and acceptance for payment by the Purchaser, of a total of approximately 573,416 Shares. Following the purchase of all of the tendered
Shares, the Purchaser will own an aggregate of approximately 3,850,776 Shares, or approximately 2.2% of the total outstanding Shares.
SIGNATURES
After due inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated:
March 11, 2024
Comrit Investments 1, Limited Partnership
|
By: Comrit Investments Ltd., its General
Partner |
|
|
|
|
|
|
|
|
By: |
/s/
Ziv Sapir |
|
|
|
|
Ziv
Sapir |
|
|
|
|
Chief
Executive Officer |
|
Comrit Investments Ltd. |
|
|
|
|
|
|
By: |
/s/ Ziv Sapir |
|
|
|
Ziv Sapir |
|
|
|
Chief Executive Officer |
|
CNL Healthcare Properties (PK) (USOTC:CHTH)
過去 株価チャート
から 10 2024 まで 11 2024
CNL Healthcare Properties (PK) (USOTC:CHTH)
過去 株価チャート
から 11 2023 まで 11 2024